| P2093 | author name string | Beatriz S Stolf | |
| | Janaina Capelli-Peixoto | |
| | Maria C A Luque | |
| | Mariana K Galuppo | |
| P2860 | cites work | Expression of neuroimmune semaphorins 4A and 4D and their receptors in the lung is enhanced by allergen and vascular endothelial growth factor | Q21263141 |
| | Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates | Q22010646 |
| | Monocytes in atherosclerosis: subsets and functions | Q22251045 |
| | Biological activity of soluble CD100. II. Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration | Q24290930 |
| | CD72 negatively regulates KIT-mediated responses in human mast cells | Q24297400 |
| | Biology and function of neuroimmune semaphorins 4A and 4D | Q24612825 |
| | Plexin-B2 negatively regulates macrophage motility, Rac, and Cdc42 activation | Q27320214 |
| | Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling | Q28140151 |
| | Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72: implications for the regulation of immune and inflammatory responses | Q28189775 |
| | Biological activity of soluble CD100. I. The extracellular region of CD100 is released from the surface of T lymphocytes by regulated proteolysis | Q28205197 |
| | Soluble SEMA4D/CD100: A novel immunoregulator in infectious and inflammatory diseases. | Q38687479 |
| | Semaphorin 4D inhibits neutrophil activation and is involved in the pathogenesis of neutrophil-mediated autoimmune vasculitis. | Q38707220 |
| | Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies | Q38917199 |
| | The role of the semaphorins in cancer | Q38929961 |
| | Semaphorins 4A and 4D in chronic inflammatory diseases. | Q38935490 |
| | Safety, Pharmacokinetics, and Pharmacodynamics of a Humanized Anti-Semaphorin 4D Antibody, in a First-In-Human Study of Patients with Advanced Solid Tumors | Q38955451 |
| | CD100 and plexins B2 and B1 mediate monocyte-endothelial cell adhesion and might take part in atherogenesis | Q38974165 |
| | Overexpression of Semaphorin4D indicates poor prognosis and prompts monocyte differentiation toward M2 macrophages in epithelial ovarian cancer | Q39052026 |
| | Distinct courses of infection with Leishmania (L.) amazonensis are observed in BALB/c, BALB/c nude and C57BL/6 mice. | Q40785827 |
| | Generation and preclinical characterization of an antibody specific for SEMA4D. | Q42393761 |
| | Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B. | Q45003993 |
| | Vascular Semaphorin 7A Upregulation by Disturbed Flow Promotes Atherosclerosis Through Endothelial β1 Integrin | Q47226703 |
| | The role of semaphorins in immune responses and autoimmune rheumatic diseases | Q47321853 |
| | The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in CD100-deficient mice | Q49157483 |
| | Semaphorin-3E attenuates neointimal formation via suppressing VSMCs migration and proliferation | Q50089075 |
| | Inflammation in human carotid atheroma plaques | Q50207221 |
| | Semaphorin 4D levels in heart failure patients: a potential novel biomarker of acute heart failure? | Q51741939 |
| | Activation of stimulator of interferon genes (STING) induces ADAM17-mediated shedding of the immune semaphorin SEMA4D. | Q52721580 |
| | Endogenous CD100 promotes glomerular injury and macrophage recruitment in experimental crescentic glomerulonephritis. | Q54468855 |
| | CD100/Sema4D Increases Macrophage Infection by Leishmania (Leishmania) amazonensis in a CD72 Dependent Manner. | Q55314129 |
| | Semaphorin 4D correlates with increased bone resorption, hypercalcemia, and disease stage in newly diagnosed patients with multiple myeloma. | Q55397591 |
| | Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions | Q57172855 |
| | Functional soluble CD100/Sema4D released from activated lymphocytes: possible role in normal and pathologic immune responses | Q73919451 |
| | Soluble CD100 functions on human monocytes and immature dendritic cells require plexin C1 and plexin B1, respectively | Q81475161 |
| | Roles of Sema4D-plexin-B1 interactions in the central nervous system for pathogenesis of experimental autoimmune encephalomyelitis | Q82354361 |
| | Deletion of Sema4D gene reduces intimal neovascularization and plaque growth in apolipoprotein E-deficient mice | Q84334793 |
| | Real-time QCM-D monitoring of endothelial cells and macrophages adhering and spreading to SEMA4D/heparin surfaces | Q90872981 |
| | The salient role of microRNAs in atherogenesis | Q90886268 |
| | CD100/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5+ B lymphocytes | Q28212106 |
| | Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation | Q28276903 |
| | Identification of CD72 as a Lymphocyte Receptor for the Class IV Semaphorin CD100 | Q29036802 |
| | The CD100 Receptor Interacts with Its Plexin B2 Ligand to Regulate Epidermal γδ T Cell Function | Q29042468 |
| | Progress and challenges in translating the biology of atherosclerosis | Q29619982 |
| | Mechanotransduction in vascular physiology and atherogenesis | Q30439086 |
| | IFN-gamma and STAT1 arrest monocyte migration and modulate RAC/CDC42 pathways | Q30490119 |
| | Disruption of SEMA4D ameliorates platelet hypersensitivity in dyslipidemia and confers protection against the development of atherosclerosis | Q30494712 |
| | Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank | Q30664833 |
| | Safety/tolerability of the anti-semaphorin 4D Antibody VX15/2503 in a randomized phase 1 trial | Q33808273 |
| | Regulation of immune cell responses by semaphorins and their receptors | Q33827421 |
| | The immune system in atherosclerosis | Q34164644 |
| | Semaphorins in interactions between T cells and antigen-presenting cells | Q34174529 |
| | Structure and function of the immune semaphorin CD100/SEMA4D. | Q34220583 |
| | The CD100-CD72 interaction: a novel mechanism of immune regulation | Q34460685 |
| | MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D. | Q34598008 |
| | Increased levels of plasma soluble Sema4D in patients with heart failure | Q34760436 |
| | Phage display identification of CD100 in human atherosclerotic plaque macrophages and foam cells | Q35010086 |
| | The semaphorins | Q35012897 |
| | Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury | Q35616359 |
| | The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions | Q35864063 |
| | Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer | Q35958869 |
| | Serum Soluble Semaphorin 4D is Associated with Left Atrial Diameter in Patients with Atrial Fibrillation | Q36131369 |
| | Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages | Q36742291 |
| | Neuroimmune guidance cue Semaphorin 3E is expressed in atherosclerotic plaques and regulates macrophage retention | Q36824150 |
| | Endothelial expression of guidance cues in vessel wall homeostasis dysregulation under proatherosclerotic conditions | Q36824156 |
| | Semaphorin signaling: progress made and promises ahead. | Q37122271 |
| | Semaphorin 4D Contributes to Rheumatoid Arthritis by Inducing Inflammatory Cytokine Production: Pathogenic and Therapeutic Implications. | Q37275562 |
| | Immune semaphorins: novel features of neural guidance molecules. | Q37344736 |
| | Myeloid cells in atherosclerosis: initiators and decision shapers | Q37399947 |
| | Monocyte and macrophage dynamics during atherogenesis | Q37890185 |
| | Atherosclerosis: current pathogenesis and therapeutic options | Q37953777 |
| | Inflammation and cardiovascular disease: from pathogenesis to therapeutic target. | Q38231099 |
| | Semaphorins in cardiovascular medicine. | Q38242970 |
| | Dynamic Aspects of Macrophage Polarization during Atherosclerosis Progression and Regression | Q38271958 |
| | Axon growth and guidance genes identify T-dependent germinal centre B cells | Q38297327 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 136 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Frontiers in cardiovascular medicine | Q27726930 |
| P1476 | title | CD100 Effects in Macrophages and Its Roles in Atherosclerosis | |
| P478 | volume | 5 | |